IR-Med Inc. (IRME)
IR-Med Inc. operates in the Medical - Devices industry of the Healthcare sector, headquartered in Rosh Pinna, HZ, IL. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $162,202. On trailing twelve-month figures it carries a trailing P/E of -0.10, a net margin of 0.0%. Its beta of 0.72 implies it has historically moved less than the broad market.
IR-Med Inc. is an emerging medical technology firm dedicated to developing advanced diagnostic and medical solutions by leveraging a platform that integrates infra-red light spectroscopy with artificial intelligence. The company's product pipeline includes PressureSafe, a handheld optical monitoring device engineered for the early identification of pressure-induced tissue damage in the skin and subcutaneous layers, often resulting from extended periods of patient immobility. Additionally, IR-Med is developing Nobiotics, an innovative otoscope designed to provide medical professionals with immediate feedback on the presence of middle ear infections (Otitis Media), a prevalent condition among pediatric patients. IR-Med Inc. operates from its headquarters in Rosh Pina, Israel.
IR-Med Inc. is most often compared with the following Healthcare names: